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Introduction  
This Master Thesis was carried out at the University of Lausanne and is part of the 
master’s curriculum in the School of Medicine(1). All manipulations have been done at the 
laboratory of the “Centre des Maladies Moléculaires” (CMM) which is part of the 
“Département Médico-Chirurgical de Pédiatrie” (DMCP) at the “Centre Hospitalier 
Universitaire Vaudois” (CHUV) (2). 
One of the research groups of the CMM works on fundamental and translational 
research on organic acidurias, mainly on glutaric aciduria type 1 (GA-1) and 
methylmalonic aciduria with a special focus on the understanding of pathophysiological 
mechanisms leading to brain damage in these diseases (2–5). 
The research exposed below is part of a subproject of the research on GA-1 which aims 
to understand the physiological role of GCDH in proximal tubular cells of the kidney and 
to elucidate whether its presence in these specific cells might be the explanation for the 
existence of two excretor types (low and high excretors) in GA-I patients (6). 
 
Background 
Glutaric aciduria type I in brief 
GA-1 is an organic aciduria, which means a defect in the catabolism of the amino acids 
lysine, hydroxylysine and tryptophan. In this disease, the gene encoding for glutaryl-CoA 
dehydrogenase (GCDH) is deficient. Its lack of function leads to the accumulation of 
glutaric acid (GA), 3-hydroxyglutaric acid (3-OHGA), glutaconic acid and glutarylcarnitine 
in body fluids (6–8). 
Although patients can present mild neurologic symptoms during the first months of life, 
the pathology appears in most cases between the ages of 6 to 18 months with the first 
metabolic crisis. Vaccinations, common infant illnesses or other catabolic states are usually 
the trigger of a first encephalopathic crisis. Patients regress in their psychomotor 
development and can secondary develop failure to thrive. Most of them do not recover 
from the first encephalopathic episode, even with appropriate treatment and diet. They 
usually develop an irreversible dystonic-dyskinetic movement disorder with preserved 
cognition (3,6). 
Typically, patients already present a macrocephaly during the first months of life 
marked by mild neurologic impairment such as hypotonia, irritability or feeding 
difficulties associated with frontotemporal atrophy and enlarged Sylvian fissures at 
neuroimaging (3,9). In addition, they are at risk of several other problems such as subdural 
haemorrhages, retinal haemorrhages, rhabdomyolysis and renal failure (3,6,8,9).  
Genetic transmission of GA-1 follows an autosomal recessive pattern and more than 200 
different mutations have been reported (7). This disorder has an estimated prevalence of 
1 in 100’000 life births with higher prevalence in several ethnic communities such as 
Canadian Oij-Cree natives, the Amish community, Irish travellers and black South Africans 
(3). 
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Lysine, Hydroxylysine and tryptophan metabolism and the function of GCDH in 
amino acid metabolism 
Lysine, Hydroxylysine and 
tryptophan have a common 
metabolic pathway from α-
acetoadipate to acetoacetate. De 
facto, those amino acids are 
ketogenic. Because of previous 
steps in its metabolism, tryptophan 
can also be named as glucogenic. 
Indeed, catabolism of tryptophan 
generates alanine and 
acetoacetate.  
 
 
 
GCDH is an obligatory step in their common pathway. It allows the transformation of 
glutaryl-CoA to glutaconyl-CoA in mitochondria (3,10). Those reactions take place mostly 
in liver. The significance of GCDH expression in kidney in the context of the different GA-
1 phenotypes is currently unclear (11).  
 
The proximal tubule of the nephron 
Nephrons can be divided in numerous functional units, typically in glomerulus, 
Bowman’s capsule, proximal tubule, Henle’s loop, distal tubule and a connective part to 
the collecting duct. Each part can vary in size depending on the cortical or juxtamedular 
position of the nephron (12,13). Following the observation of juxtamedular expression of 
GCDH (11), we hypothesized that proximal tubular epithelial cells (PTECs) might have 
different functions in amino acid metabolism depending on their place in the renal cortex. 
This affirmation requires further investigations.  
The proximal tubule is coated with highly specialized epithelia showing numerous 
specificities linked to their functions. PTECs or nephrocytes are polarized cells (14). To 
share the maximal surface with primary urine they display a large apical brush border and 
have processes that interdigitate cells at the basal lamina pole. To support their intense 
metabolic function, they contain a large amount of mitochondria, which make them 
acidophilic. Finally, these cells are joined at the apical pole by tight junctions (12,13).  
 
GA-1 and the kidney 
Significant co-expression of GCDH and organic anion transporter 1 (OAT1) was found 
in the juxtamedular area of rat kidney (11). The same co-localisation was found in neurons, 
which let to the hypothesis of a functional coupling of both proteins (11). This hypothesis is 
supported by the possibility that residual GCDH activity leads to the “low excretor” 
phenotype and complete absence of enzyme activity to the typical urinary pattern of “high 
excretor” GA-1 patients (3).  
In the nephron, the proximal tubule is specialized in reuptake, excretion and 
transformation of several components of primary urine and in particular of amino acids 
(12,14). This explains why PTECs are thought to display a particular role in GA-1.  
  
Figure 1: lysine, hydroxylysine and tryptophan metabolism 
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Urinary sediment microscopic analysis of healthy volunteers  
Urine is commonly seen as a complex mix of body waste. In urine, we can find many 
precipitated crystals. They have no real relevance for the culture of PTECs, but they can 
give much information on urine quality. Following the same idea, direct microscopic 
visualisation of the pellet can show fungal, bacterial or parasitic infection of the subject. In 
urine sediment, besides PTECs some other cells types can be found such as squamous 
epithelial cells that are the most common cells in a normal pellet and transitional epithelial 
cells. Tubular epithelial cells, erythrocytes and lymphocytes are pathologic if they are 
present in large amounts. We can also see abnormal cells in urine sediment, for example 
neoplastic cells or caudate epithelial cells (15–23). 
Specificities of PTECs as an in vitro culture system 
Techniques to collect and study PTECs over a long time 
Some groups harvested cells from nephrectomised kidneys and used different 
protocols to collect more or less specifically PTECs (24–27). However, harvesting PTECs 
from fresh urine is a valuable alternative (24,28–31). A possibility to use PTECs over a 
longer period for research is to transform them secondarily into immortalized cell lines 
(24,25,28,32,33).  
The validity of cell lines derived from fresh urine has been questioned. It was thought 
that an apoptosis-induced mechanism was responsible for the exfoliation. However, it has 
been shown that cells keep their normal morphology and function. The actual explanation 
is a regulation of overcrowding by exfoliation due to a constant proliferation and migration 
of PTECs (24).  
As a conclusion, cultivation of PTECs derived from fresh urine seems to be a non-
invasive and equivalent technique to PTECs derived from nephrectomy (24).  
Techniques to isolate PTECs using flow cytometry 
Van der Hauwaert et al. exposed a way to isolate PTECs using flow cytometric technics 
(26). As immunostaining is involved, they proposed the use of CD10 and CD13 as specific 
labelling for PTECs. Indeed, double positive cells seem to be derived from all segments 
of the nephron’s proximal tubule. The use of fluorescent activated cells sorter (FACS) 
permits the selection of cell populations based on their labelling. They thus proposed a 
standard protocol for the establishment of pure PTEC lines.  
Regeneration and stem cells of the proximal tubule 
Tubular cells have a large regenerative capacity and can recreate the normal 
microanatomy of the nephron after severe tubular injury. Recently, a new cell type called 
robust cells was discovered showing specific morphology and several stem cell markers. 
They seem to be involved in regeneration of tubules (25).  
Due to their robustness to injury and their high potential of regeneration, especially in 
regeneration of the proximal tubule, those cells could be an alternative to the use of PTECs 
for our project (26). The creation of PTECs derived from stem cells is theoretically also 
possible.  
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Epithelial to mesenchymal transition (EMT) 
After some passages, morphological and immunohistochemical modifications of PTECs 
can be observed. The moment of these changes can vary (34).  
Those modifications include loss of polarity, reduction in cell density and a 
myofibroblatic aspect. In addition, the appearance of vimentin, a mensenchymal marker, 
can be observed by immunohistochemistry (27,34–36).  
Several studies tried to understand the mechanisms involved in EMT (27,34–37). The 
same mechanism is thought to be involved in renal fibrosis after chronic injuries inducing 
persistent proteinuria (34). As a result, PTECs seem to start EMT when they are in contact 
with components of pathologic primary urine, particularly with inflammatory mediators 
such as C3a (27).  
Possibility of culturing children’s cells and its yield 
Historically, PTECs were tried to be cultured to study amniocentesis. It was thought that 
the cells used to build a karyotype were of renal origin (38).  
Further research focused on describing the evolution of cultured epithelial cells from 
fresh urine (30,39). Several groups used cells harvested from urine to build in vitro models 
for numerous diseases and escaping invasive biopsy to get pathological cells (28,29,31). 
Many studies used children’s urine, from new-borns to young adults, and surprisingly, 
the yield of children’s urine is higher than for adults (28–31). An average number of 3 
(range of 0.3 to 19) colonies per 1ml of urine is described to be obtained for children while 
for adults the yield is only at 1-10 colonies per 100 ml of urine (30). 
As a conclusion, PTEC cultures derived from fresh children’s urine give a higher yield 
per urine volume compared to cultures derived from adults and are an excellent model to 
study different diseases in these cells thus avoiding renal biopsy. 
Contamination risks  
Due to the non-sterile origin of the sample, PTEC cultures derived from fresh urine are 
at high risk for contaminations. Moreover, many antifungals and antibiotics usually used in 
cells cultures are toxic for PTECs and should be avoided, such as gentamycine and non-
liposomal amphotericine B. As a consequence, there is a need for a close microbiological 
follow-up of samples.  
Aims of the project 
As a middle term objective, the research group in which this master thesis was 
performed wants to generate an in vitro model of immortalized PTECs derived from low 
and high excretor GA-1 patients and healthy aged-matched controls. This biologic tool will 
provide a useful model for further research on physiological GCDH function in PTECs and 
its pathophysiological consequences in GA-1 patients.  
On the other hand, the development of protocols for collection and culture of urinary 
sediment cells leading to pure single-cell cultures by specific selection is a powerful tool 
for multiple laboratory investigations e.g. the establishment of cultures from fresh urine 
samples could avoid skin biopsies in patients for which biochemical, enzymatic or genetic 
analyses have to be performed on fibroblasts.  
The aim of this master thesis was to establish a protocol for the collection, culture and 
immortalization of PTECs from fresh urine of healthy volunteers.   
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Material and methods 
Ethic statement  
This experiment has been approved by the “Commission cantonale d’éthique de la 
recherche sur l’être humain” (CER-VD).  
Urine sediment harvest and pellet seeding 
Protocol 
As described below, two conditions of basal medium were tested. As the contamination 
risk was relatively high, several precautions were required, such as using sterilized 
collecting bottles and sterile wipes moist with non-alcoholic chlorhexidine (Braun Medical, 
#19286) to disinfect genitalia. In addition, several other precautions were tested such as 
screening of urine portions with urinary sticks (Zambon© Monulab) for nitrite and leucocytes 
or the avoidance of females as volunteers. An early antifungal treatment with 
Amphotericin-B (Sigma-Aldrich: A2942-20ML) was also tried. 
Urinary sediments were centrifuged at 1’600 rpm (280 N) for 15 min at room 
temperature. Pellets of 0.5 to 1ml were seeded in TC-treated 12 well-plates (Costar® 12 Well 
Clear TC-Treated Multiple Well Plates, #3512) with 3 ml of standard medium. Culture plates 
were placed in an incubator at 37 °C and 5 % CO2. 
 
Basal medium 1: 
DMEM/Ham's F-12 liquid medium with stable glutamine (BIOCHROM #FG 
4815) supplemented with: T3, epinephrine, rhEGF, Hydrocortisone, insulin, 
transferrin from REGM SingleQuot Kit Suppl. & Growth Factors (Lonza #CC-
4127), 5 ng/ml Sodium selenite (Catalog Number S5261 Sigma-Aldrich Co), 3.4 
μg/ml β-Nicotinamide adenine dinucleotide hydrate (Catalog Number N3014 
Sigma-Aldrich Co), 100 U/ml-100microg/ml penicillin-streptomycin (Catalog 
Number 15140122 Life Technologies) and 10 % heat-inactivated Foetal Calf 
Serum (FCS) (BioConcept Ltd. Amimed  2-01F100-I). 
Basal medium 2: 
DMEM/Ham’s F-12 standard medium (Gibco® 11330-032) basically 
supplemented with: 100 U/ml-100microg/ml Penicillin-Streptomycin 
(Gibco® 15140-122), 10 ng/ml EGF (Sigma-Aldrich: E9644-2MG), 35 ng/ml 
Hydroxycortisone (Sigma-Aldrich H0888-1G), 5 ng/ml insulin (Sigma-Aldrich I-
5500), 6.4 ng/ml T3 (Sigma-Aldrich T-2752), 5 ng/ml sodium selenite (Catalog 
Number S5261 Sigma-Aldrich Co) and 1.25 μg/ml Fungizone (Amphotericin-B) 
(Sigma-Aldrich A2942-20ML) until first medium change.  
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Cell culture 
Protocol  
The first medium change was performed at 24 h. It was a 5/61 medium removal. If a lot 
of waste was observable (crystals, squamous cells…), full medium removal with PBS (1x; 
37°C) washing was performed. Before disposal in the incubator, 3 ml of medium were 
added.  
Standard 5/6 medium changes were performed every 3 days until cells started to 
detach from the ground of the first colony.  
When cells started to detach from the ground of the colony, the medium was collected 
and seeded in another well. This new culture followed exactly the same protocol as the 
primary culture. The harvest of cells from culture medium can occur every 3 days.  
Culture maturity was achieved when cells covered the whole plate surface, when cells 
stopped growing or when the first signs of EMT appeared.  
Culture analyses 
Daily follow-up 
Cell morphology, colony biodynamics and health of cultures were analysed by direct 
microscopy with photo documentation as follow-up (Jenoptik easyshot and Leitz Labovert) 
completed by personal notes.  
Immunostaining  
Cellular characterisations were studied using immunohistochemistry and 
immunofluorescence technics. Several protocols were tested. 
General protocol 
For each tested cellular substrate, the following manipulations were performed. After 
fixation in paraformaldehyde 4% (PAF) (P6148 Sigma-Aldrich,) cells were washed 3𝑋5 min 
in PBS 1x, endogenous peroxidases were inactivated using a bath of H2O2 1.5% associated 
with Triton 0.1 % to permeabilize cell membranes during 15 min. After a second run of 
wash, epitopes were blocked using PBS-Bovine Serum Albumin 1 % (PBS-BSA). Primary 
antibodies were incubate overnight at 4 °C. Before incubation with the secondary 
antibodies at the recommended dilution, a third run of wash was performed.  
For immunohistochemistry, secondary antibodies coupled with horseradish 
peroxidase (HRP) were incubated 1h30 at room temperature. Revelation of labelled cells 
was performed using AEC Chromogen substrate.  
For immunofluorescence, secondary antibodies coupled with fluorochrome were 
incubated 1h30 at room temperature in the dark. A DAPI fluorescent staining was 
performed when possible.  
Cellular substrate alternatives  
 
Direct immunostaining in the culture well:  
 
Immunostaining was directly performed in the culture well after fixation with PAF 
 
                                                     
1 Remove 5 of 6 parts of old medium.  
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Immunostaining on coverslips: 
 
We added sterile glass coverslips (microscope cover glasses (Assistant: 1001/20)) to the 
culture wells in order to let cells grow on it and use them thereafter for immunostaining. 
Glass coverslip were sterilized by placing them in Becher containing pure ethanol before 
burning them on a bec Bunsen flame.  
 
Immunostaining of a monolayer cell membrane: 
 
Cell monolayers were scratched from culture wells using sterile scalpels and tissue 
plier to get cell membranes. They were fixed in PAF after their disposal on immunostaining 
glass slides. 
 
Immunostaining of cells in suspension: 
 
Culture medium was harvest in 15 ml Falcons®. Cell monolayers were washed with PBS 
1x, at 37 °C. The washed product was transferred into Falcons®. Trypsinisation using 
TrypLE™ Express solution (LifeTechnologies 12604013) until cell detachment was 
performed. Cells suspensions were harvested in Falcons® where 1 ml FCS was added. 
Volume was completed with PBS 1x. It underwent a centrifugation at 1’600 rpm (280 N) for 
10 min. Supernatant was removed. After a PAF incubation of the pellet in the Falcon® during 
1 h, a centrifugation at 1’600 rpm for 10 min was performed. The supernatant was then 
removed, followed by an incubation with 12 % sucrose overnight. After centrifugation at 
1’600 rpm for 10 min, the supernatant was again removed. A second incubation in 18% 
sucrose during 4 h was performed. The Falcon® underwent a last centrifugation at 1’600 
rpm for 10 min. The supernatant was removed leaving 0.5 ml of liquid. The pellet was 
suspended in the residual volume. The suspension was then transferred into a 1 ml 
Eppendorf® tube.  
In a 200 µl PCR Eppendorf® tube, 100 µl of optimal cutting temperature compound 
(OCT) was added. Cell suspensions were briefly quick spinned. Supernatant was removed. 
The pellet was carefully disposed in OCT by pipetting. The volume of the 200 µl PCR 
Eppendorf® tube was competed with OCT. PCR Eppendorf® tubes containing cell solutions 
in OCT were disposed in a liquid nitrogen bath to be cryogenized. Products were stored 
in a -80°C freezer waiting to be cut with a Cryostat. 
During cutting with the Cryostat, a regular control of cell presence was performed by 
the help of DAPI labelling.  
Markers  
Primary antibodies:  
 Pancytokeratin (PCK) (Santa-Cruz 15367) as epithelial marker.  
 Gamma-glutamyltranspeptidase 1 (GGT1) (Santa-Cruz 166908) to label a brush-
border enzyme. It gives the indication of polarity, cell phenotype preservation 
and tubular origin of cells.  
 Zonula occuldens 1 (ZO-1) (Santa-Cruz 8147) as epithelial marker and polarity 
marker.  
 Glutaryl-CoA dehydrogenase (GCDH) (Sigma AV43559) to label central protein 
in GA1 pathogenesis. 
 CD10 (eBioscience 17-0106-42), almost specific markers for PTECs2  
 Vimentin (V4630, Sigma) as epithelial-to-mesenchymal transition marker  
                                                     
2 cf flow cytometry results 
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Secondary antibodies:  
 Goat anti-mouse 555 (Lifetechnology A21422) 
 Goat anti-rabbit 350 (Invitrogen A21068) 
 Donkey anti-rabbit 555 (Invitrogen A31572) 
 Goat anti mouse HRP (BIO RAD 1706516) 
 Donkey anti-goat HRP (Santa-Cruz sc-2020) 
 Goat anti-rabbit HRP (BIO RAD 1706515) 
Flow cytometry 
This experiment was realized at the Ludwig Institute in Epalinges with the precious 
help of Anne Wilson, Stefanie Siegert and Catherine Fumey.  
In order to determine the proportion of PTECs in culture, we passed suspended cells 
labelled with anti-CD13 conjugated with PE (CD13-PE) and anti-CD10 conjugated with APC 
(CD10-APC) on a fluorescent activated cells sorter (FACS). 
Standards marker dilutions were obtained by titration on human peripheral blood 
lymphocytes (human PBL).  
A cell suspension was obtained using TrypLE™ Express (LifeTechnologies 12604013) 
to spare epitopes from enzyme digestion. Trypsinization was stopped using standard 
medium. After centrifugation at 1650 rpm for 5 min, the supernatant was removed and 
EDTA 5 mmol/l with PBS-FCS 2 % buffer was added to avoid aggregation. Markers were 
added at standard dilution (1:100 for CD10-APC and 1:200 for CD13-PE). After an 
incubation of 20 min at 4 °C two rounds of washing with PBS 1x were performed. The final 
cell suspension was stained with DAPI.  
Samples were analysed using the BD LSR 11b engine for flow cytometry analysis and 
Amnis Mark II to combine flow cytometry and microscopy analysis.  
We analysed 12 samples of urinary sediment cells cultured with the standard protocol. All 
samples derived from the same subject. 
For each sample, 20’000 cells were analysed and named as events. The proportion of living 
cells was determined by subtracting DAPI-positive cells (DAPI+) to all the events. In DAPI- 
population, subpopulations of cells were determined by their labelling in order to get 
subpopulations of double positive cells CD10+/CD13+, simple positive cells 
CD10+/CD13-, simple positive cells CD10-/CD13+ and double negative cells CD10-
/CD13-. All observations were materialized on graphics (Figure 2) and on numeric values 
(cf annexes). 
 
 
Figure 2: example of FACS analysis. The axes 
show the labelling intensity signal on cells for 
CD10 and CD13 labelling. Colours express the 
density of cells in this range of labelling intensity. 
Blue expresses the lowest density and red the 
highest. The horizontal line expresses the level of 
CD10 labelling intensity where the signal is 
higher than the background. The vertical line 
expresses the same for CD13 labelling. As 
consequence, we obtained four subpopulation 
groups which correspond to Q1=CD10+/CD13-, 
Q2=CD10+/CD13+, Q3=CD10-/CD13+ and 
Q4=CD10-/CD13-. In this example, we saw three 
cell subpopulations corresponding to Q2, Q3 and 
Q4. The biggest and most homogenous 
subpopulation group is in Q2 which corresponds 
to CD10+/CD13+.  
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In addition to these observations, flux cytomorphometry analysed several geometrical 
characteristics (cf annexes) and generated cell pictures (figure 3). Ten samples were 
analysed by this modality.  
Flow cytometry coupled to microscopy with CD10 and CD13 labelling  
Unstained 
 
Figure 3:CD10/CD13 labelling. First 
column: native cells. Second column: 
CD13 labelling. Third column: CD10 
labelling. Fourth column: side scatter 
fluorescence that shows cell granularity. 
No CD10+/CD13- subpopulation was 
observable. 
 
CD10+/CD13+ 
 
CD10-/CD13+ 
 
CD10-/CD13- 
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pRNS-1 amplification  
Getting immortalized PTECs lines was one of the objectives of this master thesis. To do 
so, a transfection by electroporation of genetic material in PTECs was thought to be a 
valuable possibility. Even if this step lacks in realisation in this master thesis, I finally got 
the material necessary to start immortalization. 
pRNS-1 is a plasmid containing an immortalization gene for eukaryotic cells. It contains 
also a resistance to ampicillin and an insertion domain. This plasmid was kindly provided 
by Petra Novotna Zavadokova.  
We performed a bacterial amplification using E. coli. Bacteria were submitted to a heat-
shock transfection with pRNS-1. Transfected bacteria were selected by an ampicillin-
supplemented medium. After bacterial amplification, pRNS-1 was harvested using the 
Maxiprep Kit (Promega).   
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Results 
Efficacy of different culture strategies 
In this section, I present the different culture methods that we tried and which 
parameters we chose for our standard protocol.  
Harvest of urine sediment 
The aim of the harvest protocol was the reduction of the risk for microbial 
contamination. In this part of the project, I analysed all seeded pellets, without 
discrimination of cellular development, from the harvest until the second medium change. 
Even if this period was chosen arbitrarily, a contamination at harvest could reasonably be 
excluded after this time period.  
The harvest protocol gave me an overall yield of non-contaminated cultures after the 
second medium change in 89.1% of all cultures.  
Several conditions were tested. We avoided female samples, used urinary sticks to 
screen for urinary infection and documented urinary pellet microbiology by microscopy. 
None of these measures seemed to have a convincing effect. We also tried to use 
Amphotericin-B as an anti-fungal drug, but its toxicity prevented the growth of urinary 
sediment cells.  
Table 1:Percentage of sterile cultures after the second medium change 
Bests conditions for urinary sediment cultures 
Basal medium 
Two basal media were tested. We analysed 
the cellular development for both basal media 
measuring cellular growth as an endpoint. No 
discrimination of growth speed or growth surface 
was performed. A major difference between 
basal media 1 and 2 was detected. In fact, 63.2 % 
of pellets cultured in basal medium 1 showed a 
cellular development while only 5.9% of pellets 
started to grow in basal medium 2.   
63,2%
5,9%
Basal media 1 (n=19)Basal media 2 (n=34)
C U L T U R E  
D E V E L O P M E N T  W I T H  
D I F F E R E N T  B A S A L  
M E D I A
Table 2: percentage of urinary pellets that 
developed in basal medium 1 and 2.  
89,1% 88,4%
90,5%
87,0%
96,6%
93,0%
All conditions
(n=64)
Male (n=43) Female (n=21) urinary stick,
male samples
(n=23)
Amphotericin-B
(n=29)
Daily follow-up
by microscopy
(n=57)
70%
75%
80%
85%
90%
95%
100%
PERCENTAGE OF STERILE 
CULTURES AFTER TWO MEDIUM 
CHANGES
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Moreover, we observed a major difference of growth speed and growth surface in 
basal medium 1.  
 
 
 
 
 
Seeding from medium  
 In order to increase the cellular growth 
surface, we tried to harvest cells in suspension 
from cultured medium. In fact, there was a time 
when cells in the middle of colonies continued to 
have mitoses, but had no more space to grow as a 
monolayer. We named this period the active 
proliferation. During this period, some cells could 
be harvest directly from the medium.  
 
 Surprisingly, the yield of cellular 
development with this manipulation was even 
higher than collection from fresh urine. We 
obtained a cellular development in 84.2% of 
seeded pellets from culture medium versus 72.7% 
of those derived from fresh urine.  
  
  
Figure 4: (A) Basal medium 1; Day in vitro (DIV) 16. It shows large amounts of cells disposed in a 
cobblestone manner / (B) Basal medium 2; DIV 17. It shows four limited cell proliferations 
 
Table 3: cellular development in cultures derived from 
fresh urine versus cells seeded from culture medium.  
72,73%
84,21%
pellets seeded from
fresh urine (n=11)
pellets seeded from
cultured medium (n=19)
CELLULAR 
DEVELOPPMENT 
A B 
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We approximately determined 
the growth area visually by giving the 
fraction of the well that was covered 
by cells (approximate well surface: 
3.8cm2 (40)). The use of this protocol 
increased dramatically our 
monolayer surface per urinary pellet. 
Without the re-seeding protocol 
cultures showed an approximate 
median growth surface of 50% while 
this could be increased to 
approximately 116.7% by addition of 
the re-seeding protocol (Table 4). 
 
 
 
Another interesting particularity of cultures derived from the re-seeding protocol was 
that their development over time was identical to the primary culture derived from fresh 
urine. In fact, they did not seem to go through the latency period (cf Developmental steps 
of urinary sediment cultures). While it took a median of 5 days to see the first colonies in 
pellets derived from fresh urine, only 1 day was necessary in those derived from the re-
seeding protocol. Moreover, when colonies appeared in re-seeded cultures, they were 
rapidly confluent, while it took a median time of 13 days to have the first confluences of 
colonies in urinary pellet cultures.  
 At the opposite, the entrance in the dedifferentiation period seems to be somehow 
coordinated. In fact, when we analysed the corrected time (time since re-seeding + age of 
the culture when the medium was collected) we saw a surprising similarity (Table 5).   
Table 4: The re-seeding protocol increased 
significantly the final number of cultured cells started from 
one pellet.  
Table 5: Cultures derived from re-seeding protocol develop first colony and first confluence of colony 
faster than primary culture derived from urine pellets. However, when corrected time is used to analyze 
moment of whole surface coverage or dedifferentiation, cultures seem to be coordinate.  
fresh urine
(n=8)
re-seeding
(n=14)
fresh urine
(n=5)
re-seeding
(n=10)
fresh urine
(n=2)
corrected
time re-
seeding (n=3)
fresh urine
(n=3)
corrected
time re-
seeding
(n=13)
time untill first colony (DIV)
time untill first confluence
(DIV)
time untill coverage of
whole surface (DIV)
time untill dedifferenciation
(DIV)
P90 8 3 14,6 10 18 20,4 19,6 21
P10 4,7 1 10,2 1 18 18 18 18,4
P50 5 1 13 3,5 18 18 18 20
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Details of urinary sediment cultures 
In this section I analysed qualitatively what I observed in urinary sediment cultures 
under standard conditions. 
Developmental steps of urinary sediment cultures 
Following my observations, PTEC cultures took an average of 19.9+/-2.5 days to reach 
maturity. This is the moment when cells reached their highest level of confluence before 
undergoing an Epithelial-to-Mesenchymatous transformation (EMT) or stopping their 
growth. The time-line of a culture can be divided into 4 periods as follows:  
1. Latency  
This initial period took an average of 5.6+/-3 days. During this time, no cell 
development was seen. Only a decrease of pellet waste was observable. This period came 
to an end when the first colony was observed. 
 
 
Figure 5: Latency. Waste of urinary sediment at DIV 1 
 
2. Primary colonies  
This period started at the discovery of the first primary colony and finished when first 
cells started to detach from primary colonies, after an average of 8.5+/-3.8 days. It was 
observed to be a short period of approximately 3 days.  
 
 
Figure 6: Primary colony. Apparition of cells at DIV 5 
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3. Active proliferation 
This period started when the first cells went into suspension and finished with the firsts 
sign of EMT or when colonies stopped their growth, after an average of 19.9+/-2.5 days. It 
was during this period that the re-seeding protocol could be successfully performed.  
 
  
  
Figure 7: Active proliferation. We see the development of the same colony from DIV 6 to DIV 14 
4. Dedifferentiation  
This period is the post mature period. Cells showed a limited expansion with growth 
arrest and underwent EMT. When EMT occurred, cells showed a significant increase of 
vimentin intermediate filament and morphological changes.  
 
  
  
Figure 8:Dedifferentiation. Immunohistochemistry, vimentin labelling, DIV 66  
40X 
400X 400X 
100X 
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FACS results 
In the 12 analysed samples, a mean of 92.3% (SD=5.5%) cells were alive (DAPI-) in the 
sample.  
In the DAPI- population, a mean of 57.3% (SD=15.7%) cells were double positive (dp) for 
CD10 and CD13, a sample median of 58.45%. The CD10 simple positive (sp) population in 
the DAPI- population represented a mean of 2.2% (SD=1.9%) and a sample median of 
1.99%. The CD13 sp population in the DAPI- population represented a mean of 32.3% 
(SD=10.1%) and a sample median of 30.55%. The double negative (dn) population in the 
DAPI- population represents a mean of 9.4 % (SD=7.9%) and a sample median of 7.73%.  
Following those results, a high proportion of cells were DAPI- at the time of analysis, which 
means that a large proportion of cells were alive and thus that the FACS results were 
interpretable. The highest subpopulation of cells in those samples were the double 
positive CD10/CD13 cells which are known to be PTECs. Two smaller subpopulation 
groups were also detected which represent other cells. 
In conclusion, the protocol of PTEC cultures derived from fresh urine pellets used for this 
experiment gave mixed cellular subpopulations with a large predominance of PTECs.  
Unfortunatelly, cytomorphometry did not show any interpretable results.  
 
Table 6: Four different cell populations could be observed in urine sediment cultures derived from 
fresh urine. 
 
Immunohistochemistry and immunofluorescence results  
In this section, I expose briefly my results for immunostaining. Manipulations were 
performed on several cellular substrates, but the protocol used for immunostaining was 
identical. Every cellular substrate was a valuable alternative except immunostaining 
directly done on cultures wells. Indeed, the plastic of the well-plate showed an important 
fluorescence at 350 nm which interfered with microscopic analysis (Figure 9). 
 
DAPI- (total of
living cells)
DAPI- CD13+
CD10-
DAPI- CD13+
CD10+
DAPI- CD13-
CD10+
DAPI- CD13-
CD10-
P90 96,25% 40,06% 75,51% 3,82% 19,69%
P10 91,98% 23,07% 41,16% 0,34% 0,52%
P50 93,25% 30,55% 58,45% 1,99% 7,73%
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Labelling revelation at 
555nm 
Labelling revelation at 
350nm 
Blank 
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suspension  
   
Membrane 
   
In well 
   
On glass 
coverslip 
   
Figure 9:This figure shows the feasibility of immunostaining on different cellular substrates. Cell 
suspensions and cell membranes can be used as cellular substrate for labelling with 555nm and 
350nm fluorochromes. Plastic fluorescence in immunostaining done directly in well culture prevent 
its use for 350nm labelling. Unfortunately, no immunofluorescence from our experiments was 
available for immunostaining on glass coverslip. But an immunohistochemistry performed on 
fibroblasts labelled for vimentin show the potential of this technic. 
 
One of the aims of this master thesis was the determination of GCDH expression in 
PTECs. As we proved the presence of PTECs using immunostaining technics during FACS 
analysis, a similar experiment was set up in immunofluorescence.  
Co-labelling of CD10 and CD13 was tried without success. PE fluorochrome of CD13-
PE was not effective in immunofluorescence. But, based on our FACS results, which showed 
a population of CD10+/CD13+ cells, but a negligible population of CD10+/CD13- in our 
sample, I can assume that CD10+ stained cells were in majority the same as the double 
Anti-CD10APC Anti-GCDH 
DAPI Anti-CD10APC 
Anti-vimentin by 
immunohisochemisrty 
Anti-vimentin by 
immunohisochemisrty 
Anti-CD10APC  Anti-GCDH 
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positive population. Thus, a simple labelling of CD10 allowed us to show the presence of 
PTECs.  
 
Immunofluorescence on membrane bound cells and cells in suspension were 
performed. It showed a co-staining for CD10 and GCDH (Figure 10).  
 
 
 CD10 labelling GCDH labelling Blank 
Membrane 
   
Membrane 
   
Cell 
suspension  
   
Cell 
suspension 
   
Figure 10: co-staining of CD10/GCDH by immunofluorescence, DIV 27. It shows a co-labelling for 
those two markers. 
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We performed an immunohistochemistry on glass coverslip during late dedifferentiation 
(DIV 66). It showed populations of cells without cohesion, showing pathologic 
morphologies such as giant cells and presenting mesenchymatous markers such as 
vimentin. Unfortunately, we did not have a valid control earlier in culture development 
(figure 9). However, the same manipulations were performed on fibroblasts and showed a 
similar staining for vimentin and gammaglutamyltranspeptidase-1.  
 
 
 
Figure 11: Immunohistochemistry with labelling for vimentin (VIM), pancytokeratin (PCK) and 
gammaglutamyltranspeptidase-1 (GGT1) at DIV 66 and on fibroblasts.  
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pRNS-1 
Our vector amplification gave two aliquots with DNA concentrations of respectively 1,6 
g/l and 1,4 g/l. Unfortunately, I have been unable to verify the quality of the amplified 
DNA by restriction corresponding to the vector card that was in our possession. This 
probably did not work because we lack knowledge on the exact pRNS-1 topography or a 
spontaneous mutation has abolished one of the restriction sites.  
Observed particularities  
Using our standard 
protocol produced a 
mysterious phenomenon. In 7 
out of 30 cultures (23.3%) 
under standard conditions, 
some cell populations started 
to roll on the surface of the 
well and to build a polypus 
formation (Figure 12). When 
they were re-seeded, cells 
grew as monolayer. That 
probably indicate the 
conservation of original cell 
differentiation. Indeed, 
neoplastic formation would 
grow in three dimension. 
Moreover, cells kept CD10 as 
immunological marker.  
 
Figure 12: First column 
shows development of polypus 
formation over 2 days. Second 
column show the re-seeding of a 
polypus formation and its 
labelling for 
immunofluorescence using DAPI 
and CD10. The membrane 
technic was chosen as cellular 
substrate. After re-seeding, 
cellular growth follows a 
monolayer fashion. 
Immunostaining shows a regular 
formation of cells expressing 
CD10.  
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Discussion 
Discussion  
The long-term aim of this master thesis was to define standard protocols for the 
research on PTECs from GA-1 patients. The specific aim was the establishment of a valid 
protocol for the harvest from fresh urine, culturing conditions, PTEC selection and 
immortalisation.  
Several experiments were performed for the proof of concept that a PTEC culture 
derived from fresh urine can be realized in the CMM laboratory of the CHUV and to 
determine the best protocols and culture conditions.  
During this master project I successfully developed a protocol for the harvest of cells 
from fresh urine. The microbiological contamination risk at two days was at 10.9% of 
seeded pellets, which represents a non-negligible problem. Daily follow-up by 
microscopy avoided transmission of contamination and other modifications reduced the 
contamination risk at two days to 7%.  
Even if literature says that the amount of tubular epithelial cells is poor in urine 
sediment from healthy volunteers (23), we obtained a cellular development in 72.7% of 
seeded pellets by using our harvest protocol and culture condition in our standard 
medium. To follow culture development, we divided the time-line of the cultures into 4 
periods. This division did not follow a classical definition, but reflects our own 
observations. In order to describe the evolution of culture, it allows an optimized timetable 
for the application of several protocols, such as the re-seeding protocol or FACS analysis.  
Our standard conditions permitted a mean area of cellular confluence of 50% of well 
surface in T-12 well-plates (approximate well surface: 3.8cm2 (40)) per harvested urinary 
pellet. As trypsinisation disturbed normal development of tubular epithelial cells and 
triggered EMT, we developed a re-seeding protocol. Its use increased 2.3 times the area 
of cellular growth without disturbing the cell’s morphology.  
Following our FACS results, we obtained a median of 58.45% of CD10+/CD13+ cells, 
which are assumed to be PTECs. In regard with Van Der Hauwaert results (26), who 
obtained 4% of double positive cells, we observed a similar morphology of epithelial cells. 
Those results showed us that our culture is not a pure PTEC culture, but our culture 
conditions seem to be partially selective for PTECs.  
We observed the development of domes, which are characteristics for epithelial cell 
cultures. Cells in our culture developed tubular and polypus formations. Even if we can 
already say that those particularities show similar markers as the other cultured cells, they 
require further investigations to determine their nature.  
Our cultures were analysed by immunohistochemistry, immunofluorescence and 
FACS. Even if those protocols should be improved, they can already be used.  
For a better selection to create pure PTEC cultures, a good alternative could be the 
use of the FACS. Indeed, we already showed that the selection of PTECs is possible using 
CD10 and CD13 markers. Further investigations should focus on the re-seeding of 
selected cells to observe their development after trypsinisation by TrypLE™ Express, 
exposition to antibodies and manipulation in FACS.  
Unfortunately, very little progress could be obtained on the immortalization of PTECs 
during this master thesis.  
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Bias 
Selection bias 
Subjects selected for this research were all young healthy adult volunteers. This does 
not correspond to the target population of further research on GA1 cell lines as this is 
predominantly an infantile population with a chronic disorder.  
We analysed only cells derived from fresh urine. We did not have a control cell line. 
We analysed selected cell lines from subjects who loose kidney cells in their urine. We do 
not know if this is the case in other population groups.  
Moreover, most of our observations were derived from a single individual.  
Analytical bias 
Most of our numerical observations were made by visual numeration and 
approximation. It is notably the case for all data about colony numbers, time and growth 
surface.  
All measures and analyses were performed by a student who gathered a certain 
experience during this master thesis. Modelling of qualitative observations was performed 
without any theoretical bases.  
Frequently, only few data were available from our experiments, therefore affecting the 
validity of our data.  
Observer bias 
Follow-up technics changed along the research. Observations can differ between 
series.  
Bias of an estimator 
Observations were performed by a single person. This could affect the objectivity of 
the results.  
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Conclusions  
This research has numerous biases and weaknesses, which are listed and detailed 
above. Nevertheless, numerous elements have been demonstrated.  
It was clearly shown that it is possible to cultivate urinary sediment cells using urine 
pellets and to get an important fraction of PTECs in these cultures. Suitable protocols to 
seed and cultivate urine sediments cells were established. Optimization of cultures without 
trypsinisation passages was also effective by using our re-seeding protocol.  
The daily observation of culture relieved different periods of urinary sediment cell 
cultures. Even if these observations would need further investigations to characterize them 
more precisely, they can already be used to prepare and document new cultures. Protocols 
for immunostaining, notably immunostaining for cells in suspension and FACS, are already 
available for use in further experiments.  
Even if several questions were solved in this master thesis, numerous steps in the 
creation of PTEC immortal lines remain unexplored. This is the case for questions about 
PTEC selection, cultivation of pure PTECs lines and immortalisation. In fact, we do not know 
if FACS is a suitable alternative to select living PTECs and re-seed them to obtain a pure 
PTEC culture. As immortalisation could not be tried in this master thesis, nothing can be 
said about the feasibility of electroporation of PTECs cultures or even the use of pRNS-1 in 
this target. GA1 patients are still the target population. We are actually unable to say if our 
protocol will lead to the establishment of such immortalized patient cell lines.   
As a conclusion, we can say that despite methodological weaknesses, this research can 
conclude on usable protocols to cultivate PTECs. Further investigations with a bigger 
population are required to get further data on selection and immortalisation of PTEC lines.  
The understanding of the pathophysiological role of GCDH in PTECs derived from the 
urine of GA1 patients is still far away from now. But this master thesis was the first step on 
the way to this goal defined by the CMM laboratory.  
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